Bristol-Myers Squibb Company (LON:0R1F)

London flag London · Delayed Price · Currency is GBP · Price in USD
46.55
+0.31 (0.67%)
At close: Nov 7, 2025
0.67%
Market Cap72.19B
Revenue (ttm)35.73B
Net Income (ttm)4.49B
Shares Outn/a
EPS (ttm)2.21
PE Ratio16.07
Forward PE7.31
Dividend1.89 (4.07%)
Ex-Dividend DateOct 3, 2025
Volume6,674
Average Volume16,408
Open46.53
Previous Close46.24
Day's Range46.39 - 46.97
52-Week Range42.54 - 63.17
Beta0.31
RSI59.63
Earnings DateOct 30, 2025

About LON:0R1F

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Sector Healthcare
Founded 1887
Employees 34,100
Stock Exchange London Stock Exchange
Ticker Symbol 0R1F
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.